|
ECB--23040741
Papers associated with cdk1 (and cdk2)
???pagination.result.count???
???pagination.result.page??? 1
| Sort Newest To Oldest | Sort Oldest To Newest |
Homology model of the CDK1/cyclin B complex., McGrath CF, Pattabiraman N, Kellogg GE, Lemcke T, Kunick C, Sausville EA, Zaharevitz DW, Gussio R., J Biomol Struct Dyn. April 1, 2005; 22 (5): 493-502. |
|
N2-substituted O6-cyclohexylmethylguanine derivatives: potent inhibitors of cyclin-dependent kinases 1 and 2., Hardcastle IR, Arris CE, Bentley J, Boyle FT, Chen Y, Curtin NJ, Endicott JA, Gibson AE, Golding BT, Griffin RJ, Jewsbury P, Menyerol J, Mesguiche V, Newell DR, Noble ME, Pratt DJ, Wang LZ, Whitfield HJ., J Med Chem. July 15, 2004; 47 (15): 3710-22. |
|
Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials., Meijer L, Raymond E., Acc Chem Res. June 1, 2003; 36 (6): 417-25. |
|
Molecular cloning and characterisation of p15(CDK-BP), a novel CDK-binding protein., Vogel L, Baratte B, Détivaud L, Azzi L, Leopold P, Meijer L., Biochim Biophys Acta. April 3, 2002; 1589 (2): 219-31. |
|
Characterization of a novel cdk1-related kinase., Détivaud L, Pettit GR, Meijer L., Eur J Biochem. August 1, 1999; 264 (1): 55-66. |
|
Synthesis and in vitro evaluation of novel 2,6,9-trisubstituted purines acting as cyclin-dependent kinase inhibitors., Legraverend M, Ludwig O, Bisagni E, Leclerc S, Meijer L, Giocanti N, Sadri R, Favaudon V., Bioorg Med Chem. July 1, 1999; 7 (7): 1281-93. |
|
Cdk2 activity is dispensable for the onset of DNA replication during the first mitotic cycles of the sea urchin early embryo., Moreau JL, Marques F, Barakat A, Schatt P, Lozano JC, Peaucellier G, Picard A, Genevière AM., Dev Biol. August 15, 1998; 200 (2): 182-97. |
???pagination.result.page??? 1